These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29162513)

  • 1. Homeostatic effect of laughter on diabetic cardiovascular complications: The myth turned to fact.
    Noureldein MH; Eid AA
    Diabetes Res Clin Pract; 2018 Jan; 135():111-119. PubMed ID: 29162513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.
    Yandrapalli S; Jolly G; Horblitt A; Sanaani A; Aronow WS
    Postgrad Med; 2017 Nov; 129(8):811-821. PubMed ID: 28749197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of laughter on post-prandial glucose levels and gene expression in type 2 diabetic patients.
    Hayashi T; Murakami K
    Life Sci; 2009 Jul; 85(5-6):185-7. PubMed ID: 19450597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular complications in diabetes mellitus.
    Sobel BE; Schneider DJ
    Curr Opin Pharmacol; 2005 Apr; 5(2):143-8. PubMed ID: 15780822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-gender-related therapeutic approaches for cardiovascular complications associated with diabetes.
    Campesi I; Franconi F; Seghieri G; Meloni M
    Pharmacol Res; 2017 May; 119():195-207. PubMed ID: 28189784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diabetic, hypertensive heart: epidemiology and mechanisms of a very high-risk situation.
    Franjic B; Marwick TH
    J Hum Hypertens; 2009 Nov; 23(11):709-17. PubMed ID: 19516273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal diabetes management during medical weight loss for cardiovascular risk reduction.
    Nori Janosz KE; Miller WM; Odom J; Lillystone M; McCullough PA
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):761-75. PubMed ID: 16076284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Control of cardiovascular risk factors in type 2 diabetes in a specialized diabetic clinic].
    Pérez-Pevida B; Varela N; Pérez Rodríguez S; Martínez Segura E; Salvador J; Escalada J
    An Sist Sanit Navar; 2017 Dec; 40(3):413-420. PubMed ID: 29215656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of MicroRNAs in Type 2 Diabetes and Associated Vascular Complications.
    Banerjee J; Nema V; Dhas Y; Mishra N
    Biochimie; 2017 Aug; 139():9-19. PubMed ID: 28487136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial glucose regulation and diabetic complications.
    Ceriello A; Hanefeld M; Leiter L; Monnier L; Moses A; Owens D; Tajima N; Tuomilehto J
    Arch Intern Med; 2004 Oct; 164(19):2090-5. PubMed ID: 15505121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative imaging biomarkers for the evaluation of cardiovascular complications in type 2 diabetes mellitus.
    Lin K; Lloyd-Jones DM; Li D; Carr JC
    J Diabetes Complications; 2014; 28(2):234-42. PubMed ID: 24309215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laughter therapy modulates the parameters of renin-angiotensin system in patients with type 2 diabetes.
    Nasir UM; Iwanaga S; Nabi AH; Urayama O; Hayashi K; Hayashi T; Kawai K; Sultana A; Murakami K; Suzuki F
    Int J Mol Med; 2005 Dec; 16(6):1077-81. PubMed ID: 16273289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humors Effect on Short-term Memory in Healthy and Diabetic Older Adults.
    Bains GS; Berk LS; Lohman E; Daher N; Petrofsky J; Schwab E; Deshpande P
    Altern Ther Health Med; 2015; 21(3):16-25. PubMed ID: 26026141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The late complications of diabetes mellitus.
    Squadrito G; Cucinotta D
    Ann Ital Med Int; 1991; 6(1 Pt 2):126-36. PubMed ID: 1742148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Review on the Protective Effect of N-Acetyl Cysteine Against Diabetes-Associated Cardiovascular Complications.
    Dludla PV; Dias SC; Obonye N; Johnson R; Louw J; Nkambule BB
    Am J Cardiovasc Drugs; 2018 Aug; 18(4):283-298. PubMed ID: 29623672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of CDKAL1 rs7756992 and IGF2BP2 rs4402960 polymorphisms in type 2 diabetes, diabetic complications, obesity risk and hypertension in the Tunisian population.
    Lasram K; Ben Halim N; Benrahma H; Mediene-Benchekor S; Arfa I; Hsouna S; Kefi R; Jamoussi H; Ben Ammar S; Bahri S; Abid A; Benhamamouch S; Barakat A; Abdelhak S
    J Diabetes; 2015 Jan; 7(1):102-13. PubMed ID: 24636221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of BNP, corin and furin as biomarkers for cardiovascular complications in type 2 diabetes mellitus patients.
    Fathy SA; Abdel Hamid FF; Zabut BM; Jamee AF; Ali MA; Abu Mustafa AM
    Biomarkers; 2015; 20(6-7):460-9. PubMed ID: 26488448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of valsartan on diabetic cardiomyopathy in rats with type 2 diabetes mellitus.
    Yang ZH; Peng XD
    Chin Med J (Engl); 2010 Dec; 123(24):3640-3. PubMed ID: 22166644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.